Clinical Trial Update: Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa

View source ↗

Summary

The prospective, longitudinal natural history study in dystrophic epidermolysis bullosa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa

Snippet

Sponsor: Lotus Tissue Repair, Inc. | Conditions: Dystrophic Epidermolysis Bullosa | Status: WITHDRAWN